Q: I would like your thoughts on this U.S. defense stocks ETF. It is performing well and I am considering buying at these levels. Do you see continued long term growth here? Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi 5iResearch Team,
Ethical issues aside, I am looking at investing in Atria Group the main businesses of which are: smokeable products, smokeless products and wine. However, I am concerned about the law suits filed by US Federal Government a couple of decades ago against tobacco companies in the States seeking major financial penalties. Would you please provide an update on these law suits. Are they still on going? If they have been settled, are there still lingering issues and the Feds could come back in future and file more law suits?
As always good work guys and your help is much appreciated.
Harry
Ethical issues aside, I am looking at investing in Atria Group the main businesses of which are: smokeable products, smokeless products and wine. However, I am concerned about the law suits filed by US Federal Government a couple of decades ago against tobacco companies in the States seeking major financial penalties. Would you please provide an update on these law suits. Are they still on going? If they have been settled, are there still lingering issues and the Feds could come back in future and file more law suits?
As always good work guys and your help is much appreciated.
Harry
Q: I am looking for an industrial income stock and am considering xtc and wsp. I think you would pick wsp because it is much bigger. I would like a yield greater than 3% and these two stocks yield just under 3%. I like the yield of Exchange Income, but am leery of the short situation. Would you please suggest a good industrial stock with a yield close to or exceeding 3%. Thanks.
Q: Dear 5i,
If I wanted USD income from a company like Enbridge, would I need to buy the stock on the NYSE and hold it in my USD trading account?
Would it pay the quarterly dividend in USD? With the CAD strengthening, is this a good strategy?
Thank you.
If I wanted USD income from a company like Enbridge, would I need to buy the stock on the NYSE and hold it in my USD trading account?
Would it pay the quarterly dividend in USD? With the CAD strengthening, is this a good strategy?
Thank you.
Q: Hi Peter and Team,
Is it CRH oversold at $4.7 level? If new billing code adopted, what is CRH worth?
Thanks
Is it CRH oversold at $4.7 level? If new billing code adopted, what is CRH worth?
Thanks
Q: Your thoughts on earnings and the fact that sales per store keep dropping. THANKYOU
Q: CRH Medical dropped >28% on Friday. I see they repaid their loan to Crown Capital as planned and have taken out a new credit facility (to 2020), reducing their interest expenses from 12% to 2.5% and providing cheaper capital for a future acquisition (3.5%), http://investors.crhsystem.com/1881-2/.
This would seem to be a big positive - quite apart from the recent re-imbursement issue which doesn't seem to realistically reflect the actual impact of any changes (i.e. is more benign than the market has anticipated).
So why the 28% drop? I got in at $4.47 - your advice, please? I'm tempted to buy more but I am/ should be an income investor (ha!).
Thanks as always,
Heather
This would seem to be a big positive - quite apart from the recent re-imbursement issue which doesn't seem to realistically reflect the actual impact of any changes (i.e. is more benign than the market has anticipated).
So why the 28% drop? I got in at $4.47 - your advice, please? I'm tempted to buy more but I am/ should be an income investor (ha!).
Thanks as always,
Heather
Q: Do you know if the Mawer New Canada Fund sold a significant part or all of its position in CRH ? If so, when did they do it ? Also when will the decision on the new reimbursement rates be final ?
Q: TD Waterhouse Action Notes Summary Report dated July 7 2017 about "Questions regarding the sustainability of CRH's reimbursement rates have contributed to a two month slide in CRH's stock."
Here's the meat of it.
" We expect a relatively benign outcome to the 2018 fee schedule, partly because of CRH's limited exposure to CMS funding. Our sensitivity analysis indicates that a 5% cut in the Medicare reimbursement fee could cost CRH ~1% in adjusted EBITDA. ....
CRH has limited exposure to MEDICARE- We expect CRH's operating performance to be largely insulated from CMS for two reasons. First, Medicare only represents 10 to 15 % of CRH's revenues. Second, CRH's dominant payers (the private insurers) employ different reimbursement protocols from Medicare. We estimate that commercial payers reimburse the 00810 code at 3X-4X the rate of government payers.
TD Investment Conclusion
We are maintaining our buy rating but reducing our target price to $10.50 (was $12).
Our rating is based on three considerations: 1) leadership in a defensive, growing segment of the U.S. healthcare services market: 2) high margin cash flow streams and: 3) expansion opportunities within CRH's core anesthesiology market.
Hope this soothes a bit!
Here's the meat of it.
" We expect a relatively benign outcome to the 2018 fee schedule, partly because of CRH's limited exposure to CMS funding. Our sensitivity analysis indicates that a 5% cut in the Medicare reimbursement fee could cost CRH ~1% in adjusted EBITDA. ....
CRH has limited exposure to MEDICARE- We expect CRH's operating performance to be largely insulated from CMS for two reasons. First, Medicare only represents 10 to 15 % of CRH's revenues. Second, CRH's dominant payers (the private insurers) employ different reimbursement protocols from Medicare. We estimate that commercial payers reimburse the 00810 code at 3X-4X the rate of government payers.
TD Investment Conclusion
We are maintaining our buy rating but reducing our target price to $10.50 (was $12).
Our rating is based on three considerations: 1) leadership in a defensive, growing segment of the U.S. healthcare services market: 2) high margin cash flow streams and: 3) expansion opportunities within CRH's core anesthesiology market.
Hope this soothes a bit!
Q: What is your opinion about this company?
Q: Please comment on LGT's purchase of 51% of the shares of Fer Pal Construction. Do you think it will make LGT more profitable?
Thank you
Jim
Thank you
Jim
Q: I know that you suggest Sun Life for a Canadian life insurance company, but how would it stack up against the potential of other life insurance companies in the US? Brian Acker recently recommended Met Life saying it was much cheaper than Sun Life. How would you compare Sun Life to US companies? Overall what Life Insurance companies would you invest in regardless of Canada or US?
Q: Hi 5i Team.
I am thinking of adding to my position on HD (currently representing about 2% of my portfolio) and would like to have your comments on this company going forward. Also would you please comment on its PE ratio as well.
Cheers,
Harry
I am thinking of adding to my position on HD (currently representing about 2% of my portfolio) and would like to have your comments on this company going forward. Also would you please comment on its PE ratio as well.
Cheers,
Harry
Q: Any idea why Cineplex is so week recently? What do you see going forward and opinion of adding to this right now?
Q: Hi team,
Following your lead and selling off ZRE for CSH.un. Is a TFSA the best account for a REIT to be held?
Thanks
Following your lead and selling off ZRE for CSH.un. Is a TFSA the best account for a REIT to be held?
Thanks
Q: I hold ENF. I recall that, in the past, you have expressed a preference for ENB - perhaps the former being more for income and the latter being more for growth. Is this correct? Is there any other reason to prefer one over the other? (Perhaps I should consider switching.)
Q: I own a lot of ER and am under water . Could you please provide your current opinion on this stock as I am considering averaging down. Thanx Robbie
Q: Within the last month I took a half position in CSH.UN, and a quarter position in DR (both in my RRSP). I am down about 6% on both. If you were to add to one of these positions today, which one would you choose, and why? Or just wait as they have negative momentum.
Paul
Paul
Q: I invest for dividends, dividend growth and some growth in stock price. I am currently holding ala but am thinking of switching enb or enf. Would you make this switch and if so which Enbridge holding ? I have a diversified portfolio.
Thank you and thanks for providing this great service
Thank you and thanks for providing this great service
Q: Some news out on WSP Global I haven't heard? Stock is down heavily on an up day.